Innovative, high-quality medical education for clinicians in cardiology and other specialties.
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Bernhard Hellmich, MD
Andreas Kronbichler, MD
Silke R. Brix, MD, MRCP, SCPR
Pearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
Matthew R. Weir, MD
Nihar Desai, MD
Ellie Kelepouris, MD, FACP, FAHA
Beyond the Broadcast: Expert Insights on SGLT2 Inhibitors in Cardiometabolic Care
Melissa Magwire, RN, MSN, CDE
Matthew Bullington, PharmD
Dawn M. Denicola, FNP-C
Keith Miller, MD
M3: Managing the Cardiometabolic Risk in MASH
Robert H. Eckel, MD, FAHA, FACC, FNLA
Naim Alkhouri, MD, FAASLD, DABOM
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Optimizing AAV Outcomes: Maintenance Therapies
Implementing the SOC Induction Therapies in AAV
Preserving Renal Function in AAV: From Novel Therapies to Practice-Changing Strategies
June 06, 2025
Vienna
Managing Patients With AAV in the Rheumatology Clinic
Revolutionizing IgAN Care in the Era of Precision Medicine: Diagnostic Approaches, Evolving Guidelines, and Novel Therapies
June 05, 2025
Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
Pulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson’s Perspective
Vallerie V. McLaughlin, MD